On June 20, 2023, the Patented Medicine Prices Review Board (PMPRB) released a proposal to amend the Interim Guidance, which sets out the approach for reviewing the prices of patented medicines under the July 1, 2022 amendments to the Patented Medicines Regulations pending the release of new guidelines (anticipated in 2024). Comments are due by August 21, 2023….
By: Smart & Biggar
By: Smart & Biggar